Combined Quinacrine and Chlorpromazine Therapy in Fatal Familial Insomnia
- 1 July 2004
- journal article
- case report
- Published by Wolters Kluwer Health in Clinical Neuropharmacology
- Vol. 27 (4) , 201-203
- https://doi.org/10.1097/01.wnf.0000134853.36429.0e
Abstract
Prion diseases are invariably fatal. Recently, quinacrine and chlorpromazine have been suggested as immediate candidates for the treatment of Creutzfeldt-Jakob disease and other prion diseases. The objective of this paper was to report on 2 fatal familial insomnia patients whose overall condition worsened despite quinacrine and chlorpromazine treatment.Keywords
This publication has 8 references indexed in Scilit:
- Evaluation of Quinacrine Treatment for Prion DiseasesJournal of Virology, 2003
- Quinacrine does not prolong survival in a murine Creutzfeldt‐Jakob disease modelAnnals of Neurology, 2002
- Drug therapy in human and experimental transmissible spongiform encephalopathyNeurology, 2002
- Acridine and phenothiazine derivatives as pharmacotherapeutics for prion diseaseProceedings of the National Academy of Sciences, 2001
- Old drugs to treat new variant Creutzfeldt-Jakob diseaseThe Lancet, 2001
- Fatal familial insomnia: clinical, neuropathological, and genetic description of a Spanish familyJournal of Neurology, Neurosurgery & Psychiatry, 2000
- Fatal familial insomnia: a new Austrian familyBrain, 1999
- Fatal Familial Insomnia and Dysautonomia with Selective Degeneration of Thalamic NucleiNew England Journal of Medicine, 1986